Valneva SE

NASDAQ:VALN

Biotechnology

Healthcare
$5.34 +0.19%

+$0.01 today

Market cap
$507.98M
Beta
1.40
P/E (TTM)
-2.9
EPS (TTM)
-$0.80
52W Low $5.06High $12.25

Volume 0.00M

Average 0.09M

Income Statement

Follow revenue through to earnings.

Revenue

$174.66M

FY 2025 · Annual

+3.0% YoY

Operating Income

-$81.63M

FY 2025 · Annual

Net Income

-$115.19M

FY 2025 · Annual

Income Statement

EUR
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue348.09M361.3M153.71M169.58M174.66M
Cost of Revenue187.92M324.44M100.88M98.54M107.14M
Gross Profit160.17M36.86M52.84M71.04M67.52M
Gross Margin46.0%10.2%34.4%41.9%38.7%
Research & Development173.28M104.92M59.89M74.14M85.3M
Selling, General & Admin71.25M57.58M96.55M95.11M74.68M
Operating Expenses221.56M150.31M134.92M57.71M149.15M
Depreciation & Amortization14.28M21.04M17.58M19.59M21.75M
EBITDA(38.74M)(104.73M)(57.72M)32.08M(50.47M)
EBITDA Margin-11.1%-29.0%-37.6%18.9%-28.9%
Operating Income(61.39M)(113.44M)(82.09M)13.33M(81.63M)
Operating Margin-17.6%-31.4%-53.4%7.9%-46.7%
Interest Income249K260K1.21M2.36M1.8M
Interest Expense16.96M19.05M23.33M23.98M41.9M
Other Income / Expenses(8.59M)(31.37M)(16.54M)(24.82M)(32.49M)
Income Before Tax(69.98M)(144.82M)(98.63M)(11.49M)(114.12M)
Pre-Tax Margin-20.1%-40.1%-64.2%-6.8%-65.3%
Income Tax Expense3.45M(1.54M)2.8M761K1.07M
Net Income(73.43M)(143.28M)(101.43M)(12.25M)(115.19M)
Net Margin-21.1%-39.7%-66.0%-7.2%-66.0%
EPS (Basic)(1.50)(2.48)(1.46)(0.17)(1.32)
EPS (Diluted)(1.50)(2.48)(1.46)(0.17)(1.32)
Weighted Avg Shares48.81M57.74M69.47M70.26M84.09M
Weighted Avg Shares (Diluted)48.81M57.74M69.31M70.26M84.09M

VALN Earnings Waterfall · TTM

NASDAQ:VALN · Revenue to Net Income

Key Ratios

EPS$-1.63
Gross Margin27.1%
Net Margin-95.9%
P/E Ratio-5.0
P/S Ratio16.7

Analysis

$156.3M of revenue converted into -$138.0M of net income for the selected period. Gross margin is 27.1% and net margin is -95.9%, showing how much revenue survives after costs and taxes. EPS is $-1.63, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
6-K6-K filingNov 13, 2026
6-K6-K filingNov 6, 2026
6-K6-K filingOct 15, 2026
6-K6-K filingOct 8, 2026
6-K6-K filingAug 14, 2026

How much revenue does VALN generate?

Valneva SE (VALN) reported $174.66M of revenue in fiscal 2025.

Is VALN profitable?

Valneva SE (VALN) reported -$115.19M of net income, with a net margin of -66.0%.